1. Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges
   Aviral Kumar et al, 2024, Pharmacological Research CrossRef
2. Insulin suppresses transcriptional activity of yes-associated protein in insulin target cells
   Samar Sayedyahossein et al, 2020, Molecular Biology of the Cell CrossRef
3. p63 regulates growth of esophageal squamous carcinoma cells via the Akt signaling pathway
   SHUAI YE et al, 2014, International Journal of Oncology CrossRef
4. Nobiletin Inhibits Cell Viability via the SRC/AKT/STAT3/YY1AP1 Pathway in Human Renal Carcinoma Cells
   Di Wei et al, 2019, Frontiers in Pharmacology CrossRef
5. YAP and TAZ Take Center Stage in Cancer
   Kun Zhang et al, 2015, Biochemistry CrossRef
6. Recombinant human bone morphogenetic protein-2 inhibits gastric cancer cell proliferation by inactivating Wnt signaling pathway via c-Myc with aurora kinases
   Kwang Bok Lee et al, 2016, Oncotarget CrossRef
7. PI3K/Akt/YAP signaling promotes migration and invasion of DLD‑1 colorectal cancer cells
   Tomoya Takeda et al, 2022, Oncology Letters CrossRef
8. SAV1 represses the development of human colorectal cancer by regulating the Akt‐mTOR pathway in a YAP‐dependent manner
   Jianwu Jiang et al, 2017, Cell Proliferation CrossRef
9. Targeting AKT for cancer therapy
   Maryam Shariati et al, 2019, Expert Opinion on Investigational Drugs CrossRef
10. The hippo pathway: A master regulator of liver metabolism, regeneration, and disease
    Anh Thu Nguyen‐Lefebvre et al, 2021, The FASEB Journal CrossRef
11. Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways
    Mao-lin Wan et al, 2020, Bioscience Reports CrossRef
12. Reactive Oxygen Species-Mediated Autophagy by Ursolic Acid Inhibits Growth and Metastasis of Esophageal Cancer Cells
    Na-Ri Lee et al, 2020, International Journal of Molecular Sciences CrossRef
13. Genome-wide transcriptome analysis reveals inactivation of Wnt/β-catenin by 3,3′-diindolylmethane inhibiting proliferation of colon cancer cells
    SUN-HEE LEEM et al, 2015, International Journal of Oncology CrossRef
14. YAP promotes the proliferation of neuroblastoma cells through decreasing the nuclear location of p27Kip1 mediated by Akt
    Xiya Shen et al, 2020, Cell Proliferation CrossRef
15. Inhibition of the interaction between Hippo/YAP and Akt signaling with ursolic acid and 3′3-diindolylmethane suppresses esophageal cancer tumorigenesis
    Ruo Yu Meng et al, 2023, The Korean Journal of Physiology & Pharmacology CrossRef
16. FOXM1-mediated downregulation of uPA and MMP9 by 3,3′-diindolylmethane inhibits migration and invasion of human colorectal cancer cells
    HUA JIN et al, 2015, Oncology Reports CrossRef
17. Hippo signaling pathway in liver and pancreas: the potential drug target for tumor therapy
    Delin Kong et al, 2015, Journal of Drug Targeting CrossRef
18. p63-Mediated activation of the β-catenin/c-Myc signaling pathway stimulates esophageal squamous carcinoma cell invasion and metastasis
    Kwang Bok Lee et al, 2014, Cancer Letters CrossRef
19. PTEN/Akt Signaling-Mediated Activation of the Mitochondrial Pathway Contributes to the 3,3′-Diindolylmethane-Mediated Antitumor Effect in Malignant Melanoma Cells
    Xiaoli Wang et al, 2020, Journal of Medicinal Food CrossRef
20. Protective Effect of Diindolylmethane against N-Butyl-N-(4-hydroxybutyl) Nitrosamine-induced Bladder Carcinogenesis
    Bhoopathy Prabhu et al, 2014, Journal of Experimental & Clinical Medicine CrossRef
21. 3,3′-Diindolylmethane potentiates paclitaxel-induced antitumor effects on gastric cancer cells through the Akt/FOXM1 signaling cascade
    HUA JIN et al, 2015, Oncology Reports CrossRef
22. WITHDRAWN: 3,3′-Diindolylmethane suppresses ovarian cancer cell viability and metastasis and enhances chemotherapy sensitivity via STAT3 and Akt signaling in vitro and in vivo
    Minghua Zou et al, 2018, Archives of Biochemistry and Biophysics CrossRef
23. Clinical Development of AKT Inhibitors and Associated Predictive Biomarkers to Guide Patient Treatment in Cancer Medicine
    Niamh Coleman et al, 2021, Pharmacogenomics and Personalized Medicine CrossRef
24. Cellular and Molecular Mechanisms of 3,3′-Diindolylmethane in Gastrointestinal Cancer
    Soo Kim, 2016, International Journal of Molecular Sciences CrossRef